PATIENTS FIRST. POWERED BY EVIDENCE. Trademark

Trademark Overview

On Tuesday, November 28, 2023, a trademark application was filed for PATIENTS FIRST. POWERED BY EVIDENCE. with the United States Patent and Trademark Office. The USPTO has given the PATIENTS FIRST. POWERED BY EVIDENCE. trademark a serial number of 98288528. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Saturday, June 29, 2024. This trademark is owned by United BioSource LLC. The PATIENTS FIRST. POWERED BY EVIDENCE. trademark is filed in the Communication Services, Computer & Software Products & Electrical & Scientific Products, Paper & Printed Material Products, Advertising, Business and Retail Services, Education & Entertainment Services, Computer & Software Services & Scientific Services, Medical & Beauty Services & Agricultural Services, Personal, and Legal & Social Services categories with the following description:

educational, training and educational testing services, namely, conducting seminars, conferences and presentations featuring topics in the field of health, medical care and pharmaceutical industries

downloadable and on-line non-downloadable technology, namely, software, platforms, digital assets, mobile applications and artificial intelligence in the field of Clinical Research, Safety Services, Risk Evaluation and Mitigation, Patient Support Services, Evidence Development and Data Analysis

training and educational services, namely, webcasting, presentations, seminars and other programs featuring topics in the field of health, medical care and pharmaceutical industries

printed materials, namely, brochures, manuals and handbooks featuring topics relating to health, medical and pharmaceutical education, training and testing in connection with patient assistance programs for the pharmaceutical and healthcare industries

consulting services in the cost and payment management of health care, namely, co-pay cards and other benefits; medical cost containment and reimbursement services to improve health, affordability and patient experience; co-pay card services, affordability consulting and program assessment; consulting services featuring analytics and information in the healthcare and pharmaceutical industries during drug development and commercialization, namely, analytics and information in the fields of real world evidence, health economics, outcomes research, payer research and market access; strategic business analysis and business advice regarding benefit management, pharmaceutical end-user behavior and healthcare use behavior; consulting services in the field of pharmacovigilance strategies to ensure regulatory compliance and patient safety in clinical trials and marketed pharmaceuticals involving human subjects; Consulting services in the fields of risk minimization, risk mitigation and Risk Eva...

safety and efficacy services, namely, risk mitigation and pharmacovigilance services, prescription drug monitoring programs, analyzing clinical data in healthcare databases, clinical trials, health economics and outcomes research in the fields of healthcare and pharmaceuticals, organizing, managing, and tracking data during development of a clinical trial, creating and updating clinical guidelines in the fields of healthcare and pharmaceuticals; consultation services in the field of research compliance, namely, regulatory compliance consultation services in the field of clinical trials involving human subjects; regulatory compliance consultation services in the field of informed consent protocols for clinical trial participants, Pregnancy registries, Pregnancy Root cause analysis, Risk Evaluation and Mitigation Strategy administration, Observational Research Real world Evidence, Real world Data, Knowledge Attitude and Behavior Surveys, Proprietary Risk Evaluation and Mitigation Strateg...

healthcare services in the nature of remote and in-person patient support services, namely, patient access and affordability and reimbursement services, nursing, dose administration and patient monitoring; clinical coordination of in-home services, structure and management of our nationwide home health network, structure and management of our nationwide injection network, PAS consulting, CRM design and implementation solutions, various technology partnerships and custom configurations connecting vendors and services, hybrid operating platform designs and deployments

medical and scientific research, namely, conducting clinical trials; basic and clinical research in the field of heath care and medicine; on-line non-downloadable technology, namely, software, platforms, applications, artificial intelligence and digital assets used to conduct, monitor, analyze or generate information related to Clinical Research, Safety Services, Risk Evaluation and Mitigation, Patient Support Services, Evidence Development and Data Analysis; non-downloadable software as a service (SAAS) technology platforms related to Clinical Research, Safety Services, Risk Evaluation and Mitigation, Patient Support Services, Evidence Development and Data Analysis
patients first. powered by evidence.

General Information

Serial Number98288528
Word MarkPATIENTS FIRST. POWERED BY EVIDENCE.
Filing DateTuesday, November 28, 2023
Status641 - NON-FINAL ACTION - MAILED
Status DateSaturday, June 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and Serviceseducational, training and educational testing services, namely, conducting seminars, conferences and presentations featuring topics in the field of health, medical care and pharmaceutical industries
Goods and Servicesdownloadable and on-line non-downloadable technology, namely, software, platforms, digital assets, mobile applications and artificial intelligence in the field of Clinical Research, Safety Services, Risk Evaluation and Mitigation, Patient Support Services, Evidence Development and Data Analysis
Goods and Servicestraining and educational services, namely, webcasting, presentations, seminars and other programs featuring topics in the field of health, medical care and pharmaceutical industries
Goods and Servicesprinted materials, namely, brochures, manuals and handbooks featuring topics relating to health, medical and pharmaceutical education, training and testing in connection with patient assistance programs for the pharmaceutical and healthcare industries
Goods and Servicesconsulting services in the cost and payment management of health care, namely, co-pay cards and other benefits; medical cost containment and reimbursement services to improve health, affordability and patient experience; co-pay card services, affordability consulting and program assessment; consulting services featuring analytics and information in the healthcare and pharmaceutical industries during drug development and commercialization, namely, analytics and information in the fields of real world evidence, health economics, outcomes research, payer research and market access; strategic business analysis and business advice regarding benefit management, pharmaceutical end-user behavior and healthcare use behavior; consulting services in the field of pharmacovigilance strategies to ensure regulatory compliance and patient safety in clinical trials and marketed pharmaceuticals involving human subjects; Consulting services in the fields of risk minimization, risk mitigation and Risk Evaluation and Mitigation Strategies; Consulting services in the field of epidemiology
Goods and Servicessafety and efficacy services, namely, risk mitigation and pharmacovigilance services, prescription drug monitoring programs, analyzing clinical data in healthcare databases, clinical trials, health economics and outcomes research in the fields of healthcare and pharmaceuticals, organizing, managing, and tracking data during development of a clinical trial, creating and updating clinical guidelines in the fields of healthcare and pharmaceuticals; consultation services in the field of research compliance, namely, regulatory compliance consultation services in the field of clinical trials involving human subjects; regulatory compliance consultation services in the field of informed consent protocols for clinical trial participants, Pregnancy registries, Pregnancy Root cause analysis, Risk Evaluation and Mitigation Strategy administration, Observational Research Real world Evidence, Real world Data, Knowledge Attitude and Behavior Surveys, Proprietary Risk Evaluation and Mitigation Strategy Platform, Expanded Patient Access Programs, Clinical Trial and Post Marketing Case Processing, Post Marketing Commitments, Post Marketing Requirements, Risk Minimization Plans, Risk Evaluation and Mitigation, Patient HUB, Benefit Investigation, Interventional Clinical Trials, Natural History Studies, Pragmatic Studies Design and Administration of Outcomes Based Agreements (or value based agreements), Federated Registries, Integrated Registries, Decentralized Studies, and Patient Recruitment Strategy
Goods and Serviceshealthcare services in the nature of remote and in-person patient support services, namely, patient access and affordability and reimbursement services, nursing, dose administration and patient monitoring; clinical coordination of in-home services, structure and management of our nationwide home health network, structure and management of our nationwide injection network, PAS consulting, CRM design and implementation solutions, various technology partnerships and custom configurations connecting vendors and services, hybrid operating platform designs and deployments
Goods and Servicesmedical and scientific research, namely, conducting clinical trials; basic and clinical research in the field of heath care and medicine; on-line non-downloadable technology, namely, software, platforms, applications, artificial intelligence and digital assets used to conduct, monitor, analyze or generate information related to Clinical Research, Safety Services, Risk Evaluation and Mitigation, Patient Support Services, Evidence Development and Data Analysis; non-downloadable software as a service (SAAS) technology platforms related to Clinical Research, Safety Services, Risk Evaluation and Mitigation, Patient Support Services, Evidence Development and Data Analysis

Classification Information

International Class038 - Services allowing people to communicate with another by a sensory means.
US Class Codes100, 101, 104
Class Status Code6 - Active
Class Status DateMonday, January 22, 2024
Primary Code038
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateMonday, January 22, 2024
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class016 - Paper, cardboard and goods made from these materials, not included in other classes; printed matter; bookbinding material; photographs; stationery; adhesives for stationery or household purposes; artists' materials; paint brushes; typewriters and office requisites (except furniture); instructional and teaching material (except apparatus); plastic materials for packaging (not included in other classes); printers' type; printing blocks.
US Class Codes002, 005, 022, 023, 029, 037, 038, 050
Class Status Code6 - Active
Class Status DateMonday, January 22, 2024
Primary Code016
First Use Anywhere DateThursday, May 31, 2018
First Use In Commerce DateThursday, May 31, 2018
International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, January 22, 2024
Primary Code035
First Use Anywhere DateThursday, May 31, 2018
First Use In Commerce DateThursday, May 31, 2018
International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateMonday, January 22, 2024
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, January 22, 2024
Primary Code042
First Use Anywhere DateThursday, May 31, 2018
First Use In Commerce DateThursday, May 31, 2018
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, January 22, 2024
Primary Code044
First Use Anywhere DateThursday, May 31, 2018
First Use In Commerce DateThursday, May 31, 2018
International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, January 22, 2024
Primary Code045
First Use Anywhere DateThursday, May 31, 2018
First Use In Commerce DateThursday, May 31, 2018

Trademark Owner History

Party NameUnited BioSource LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBlue Bell, PA 19422

Trademark Events

Event DateEvent Description
Friday, December 1, 2023NEW APPLICATION ENTERED
Monday, January 22, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 18, 2024LETTER OF PROTEST EVIDENCE FORWARDED
Wednesday, June 26, 2024ASSIGNED TO EXAMINER
Saturday, June 29, 2024NON-FINAL ACTION E-MAILED
Saturday, June 29, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, June 29, 2024LETTER OF PROTEST EVIDENCE REVIEWED - ACTION TAKEN
Saturday, June 29, 2024NON-FINAL ACTION WRITTEN
Monday, September 30, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, September 30, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Related Keywords

evidence powered first patients services clinical namely research patient risk health field mitigation healthcare